Year All2024202320222021202020192018201720162015 Poseida Therapeutics Announces Series A Financing December 16, 2015 Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies August 11, 2015 Poseida Therapeutics, Inc., Expands Board of Directors August 5, 2015 Poseida Therapeutics to Participate in Jefferies 2015 Healthcare Conference June 1, 2015 Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies June 1, 2015
Poseida Therapeutics, Inc. Announces Worldwide License Agreement With Janssen to Apply Centyrin Technology in the Development of Chimeric Antigen Receptor (CAR) Therapies August 11, 2015
Poseida Therapeutics, Inc., Expands Into JLABS to Foster Research Collaboration With Janssen for Development of Allogeneic CAR-T Therapies June 1, 2015